CervoMed Inc. (CRVO)

NASDAQ: CRVO · Real-Time Price · USD

2.650

+0.020 (0.76%)

At close: Aug 25, 2026, 4:00 PM EDT

2.620

-0.030 (-1.13%)

Pre-market: Aug 26, 2026, 6:09 AM EDT

CervoMed Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	22.46	8.24	9	7.79	4.09	6.67
Short-Term Investments	2.48	12.63	29.92	-	-	-
Cash & Short-Term Investments	24.94	20.86	38.92	7.79	4.09	6.67
Cash Growth	-25.63%	-46.39%	399.46%	90.37%	-38.59%	-
Accounts Receivable	-	0.43	2.25	0.92	-	-
Other Receivables	-	-	-	-	-	0.07
Receivables	-	0.43	2.25	0.92	-	0.07
Prepaid Expenses	0.73	1.27	1.91	1.26	0.06	0.02
Other Current Assets	0.32	0.32	-	-	-	0.05
Total Current Assets	25.99	22.88	43.08	9.96	4.16	6.82
Other Long-Term Assets	-	-	-	0.01	-	-
Total Assets	25.99	22.88	43.08	9.97	4.16	6.82

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	0.69	1.45	1.51	0.66	0.1	0.02
Accrued Expenses	2.29	3.12	2.25	1.84	0.59	0.4
Current Portion of Long-Term Debt	-	-	-	-	12.41	4.11
Other Current Liabilities	0.05	0.08	0.12	0.09	0.05	0.03
Total Current Liabilities	3.03	4.66	3.88	2.6	13.16	4.56
Long-Term Debt	-	-	-	-	-	5.92
Total Liabilities	3.03	4.66	3.88	2.6	13.16	10.47

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.01	0.01	0.01	0.01	0	0
Additional Paid-In Capital	135.18	115.91	109.87	61.81	18.98	18.52
Retained Earnings	-112.23	-97.7	-70.73	-54.44	-52.27	-46.47
Comprehensive Income & Other	0	0.01	0.06	-	-	-
Total Common Equity	22.96	18.22	39.2	7.38	-33.29	-27.94
Shareholders' Equity	22.96	18.22	39.2	7.38	-9	-3.66
Total Liabilities & Equity	25.99	22.88	43.08	9.97	4.16	6.82

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	-	-	-	-	12.41	10.03
Net Cash (Debt)	24.94	20.86	38.92	7.79	-8.32	-3.36
Net Cash Growth	-25.63%	-46.39%	399.46%	-	-	-
Net Cash Per Share	2.62	2.31	4.82	2.93	-16.06	-0.75
Filing Date Shares Outstanding	15.12	9.26	8.7	6.17	4.5	4.5
Total Common Shares Outstanding	13.53	9.25	8.7	5.67	4.5	4.5
Working Capital	22.96	18.22	39.2	7.37	-9	2.26
Book Value Per Share	1.70	1.97	4.50	1.30	-7.39	-6.21
Tangible Book Value	22.96	18.22	39.2	7.38	-33.29	-27.94
Tangible Book Value Per Share	1.70	1.97	4.50	1.30	-7.39	-6.21

SEC Filings: 10-K · 10-Q